Floatz logo

Mifepristone

Psychotic Depression

Corcept TherapeuticsSmall moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Psychotic Depression cohort.

Asset / SponsorPhaseRating
CITALOPRAM
Massachusetts General Hospital
Phase 3BB
Cipralex
Massachusetts General Hospital
Phase 3BB
Sertraline
Massachusetts General Hospital
Phase 3BB

Same molecule, other indications

Mifepristone is also rated in:

psychotic disorderDormant
BB
Indicative ·
64 / 100
View asset →
major depressive disorderDormant
B
Indicative ·
63 / 100
View asset →
Cushing syndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →